x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

91 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

FRANCIA

ILE-DE-FRANCE
PARIS

A Phase I, Multi-center, Open-label Study of LEE011 in Patients With Malignant Rhabdoid Tumors and Neuroblastoma - FR
CLCC Institut Curie
Département d'Oncologie pédiatrique, adolescents et jeunes adultes

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
ADDRESS: NOT PROVIDED - UK

REGNO UNITO; GRAN BRETAGNA

Greater Manchester
MANCHESTER

REGNO UNITO; GRAN BRETAGNA

South Yorkshire
SHEFFIELD

REGNO UNITO; GRAN BRETAGNA

South Yorkshire
SHEFFIELD

SPAGNA

Andalucía
SEVILLA

Sperimentazione in fase di reclutamento
Sperimentazione in corso
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

AUSTRIA

WIEN
WIEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Malignancies - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

BELGIO

VLAAMS BRABANT
LEUVEN

A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma- BE (completed)
University Hospitals Leuven - Gasthuisberg
General medical oncology/Algemene Medische Oncologie

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

ILE-DE-FRANCE
VILLEJUIF

FRANCIA

NOUVELLE AQUITAINE
BORDEAUX

FRANCIA

NOUVELLE AQUITAINE
BORDEAUX

Sperimentazione in fase di reclutamento
Sperimentazione in corso
Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study (Phase II) - FR
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANIA

Nordrhein-Westfalen
MÜNSTER

Doxo: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE - Completed
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

REGNO UNITO; GRAN BRETAGNA

Tyne & Wear
NEWCASTLE UPON TYNE

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

SPAGNA

Madrid
MADRID

Sperimentazione in corso
Randomized, double-blind, 3-arm trial to evaluate the impact of blood loss following administration of three tranexamic acid regimens in patients undergoing bone or soft tissue sarcomas (Phase III) - ES
IdiPAZ - Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Unidad Central de Investigación Clínica y Ensayos Clínicos del Hospital La Paz

SVIZZERA

Suisse Alémanique
ST. GALLEN

Sperimentazione in fase di reclutamento
Sperimentazione in corso
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
Kantonsspital St. Gallen
Klinik für Neurologie und Klinik für Hämatologie/Onkologie

SVIZZERA

Suisse Romande
LAUSANNE

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Sperimentazione in corso
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Sperimentazioni cliniche internazionali